Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases

Journal of Rheumatology

Volumn 23, Issue 10, 1996, Pages 1784-1787

  Sullivan, Elizabeth A ^a,b,d   Staehling, Norman ^a,c   Philen, Rossanne M ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Health Studies Branch   (United States)

^c Biostatistics Branch   (United States)

^d LIVERPOOL HOSPITAL   (Australia)

Author keywords

eosinophil; eosinophilia myalgia syndrome; L tryptophan

Indexed keywords

TRYPTOPHAN;

ADULT; ARTICLE; CONTROLLED STUDY; EOSINOPHILIA MYALGIA SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; DISEASE OUTBREAKS; EOSINOPHILIA-MYALGIA SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; TRYPTOPHAN;

EID: 0029825261     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention: Eosinophilia-myalgia syndrome - New Mexico. MMWR 1989;38:765-7.
2. Centers for Disease Control and Prevention: Eosinophilia-myalgia syndrome and L-tryptophan-containing products - New Mexico, Minnesota, Oregon, and New York, 1989. MMWR 1989;38:785-8.
3. Slutsker L, Hoesly FC, Miller L, et al.: Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. JAMA 1990;264:213-7.
4. Hertzman PA, Blevins WL, Mayer J, Greenfield B, Ting M, Gleich GJ: Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 1990;322:869-73.
5. Belongia EA, Hedberg CW, Gleich GJ, et al.: An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 1990;323:357-65.
6. Philen RM, Eidson M, Kilbourne EM, Sewell M, Voorhees R: Eosinophilia-myalgia syndrome. A clinical case series of 21 patients. Arch Intern Med 1997;151:533-7.
7. Kamb ML, Murphy JJ, Jones JL, et al.: Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients. JAMA 1992;267:77-82.
8. Back EE, Henning KJ, Kallenbach LR, Brix KA, Gunn RA, Melius JM: Risk factors for developing eosinophilia-myalgia syndrome among L-tryptophan users in New York: J Rheumatol 1993;20:666-72.
9. Henning KJ, Jean-Baptiste E, Singh T, Hill RH, Friedman SM: Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan. J Rheumatol 1993;20:273-8.
10. Swygert LA, Macs EF, Sewell LE, Miller L, Falk H, Kilbourne EM: Eosinophilia-myalgia syndrome results of national surveillance. JAMA 1990;264:1698-703.
11. SAS Institute Inc.: SAS/STAT User's Guide, Release 6.03 edition. Cary, NC: SAS Institute Inc., 1988.
12. Hill RH Jr, Cauttill SP, Philen RM, et al.: Contaminants in L-tryptophan associated with eosinophilia-myalgia syndrome. Arch Environ Contam Toxicol 1993;25:134-42.
13. Mayeno AN, Lin F, Foote CS, et al.: Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome. Science 1990;250:1707-8.
14. Smith MJ, Mazzola EP, Farrell TJ, et al.: 1,1′-ethylidenebis (L-tryptophan), structure determination of contaminant "97" implicated in the eosinophilia-myalgia syndrome. Tetrahedron Lett 1991;32:991-4.
15. Mayeno AN, Belongia EA, Lin F, Lundy SK, Gleich GJ: 3-(Phenylamino)alanine, a novel aniline derived amino acid associated with eosinophilia-myalgia syndrome: A link to toxic oil syndrome? Mayo Clin Proc 1992;67:1134-9.
16. Love LA, Rader JI, Crofford LJ, et al.: Pathological and immunological effects of ingesting L-tryptophan and 1,1′-ethylidenebis (L-tryptophan) in Lewis rats. J Clin Invest 1993;91:804-11.
17. Silver RM, Ludwicka A, Hampton M, et al.: A murine model of the eosinophilia-myalgia syndrome induced by 1,1′-ethylidenebis (L-tryptophan). J Clin Invest 1994;93:1473-80.
18. Patmas MA: Eosinophilia-myalgia syndrome not associated with L-tryptophan. N Jersey Med J 1992;89:285-6.
19. Hertzman PA, Clauw DJ, Kaufman LD, et al.: The eosinophiliamyalgia syndrome: Status of 205 patients and results of treatment 2 years after onset. Ann Intern Med 1995;122:851-5.
20. Philen RM, Posada M: Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization Meeting Report. Semin Arthritis Rheum 1993;23:104-24.